Health Care · Euronext Paris · FYE 12-31 · Prices AT CLOSE 2026-08-18 (EUR) Last €0.73 · Day +0.41% · Mkt cap $231M · 1Y −29.2% · Off 52W high −51.4% · Vol (1Y) 51.3% Price2023-08-18 → 2026-08-18 TNG.PA close: EUR 1.70 on 2023-08-18 to EUR 0.73 on 2026-08-18. Split-adj closes · 240 of 4,189 · price returnⓘ At a glance No fair-value, short-interest or ownership figures on file for TNG.PA. Key fundamentalsFY 2025 | Sales (TTM)€7.2M | | Earnings (TTM)-€37.5M | | ROE−54.8% | | Net margin−520.4% | | ROIC−43.9% | | Debt / equity0.02× | | Sales growth 3Y−11.3% |
FY ratios · TTM sales/earnings (EUR)ⓘ Trailing returns | YTD−24.1% | | 1Y−29.2% | | 3Y−57.1% | | 5Y−67.7% | | 10Y−72.8% | | Since incept. (ann.)−18.1% |
Total return · from 2010-01-04ⓘ Risk | Ann. volatility (1Y)51.3% | | Ann. volatility (3Y)54.9% | | Sharpe (1Y)−0.45 | | Sharpe (3Y)−0.29 | | Max drawdown (1Y)−52.1% | | Max drawdown (3Y)−69.1% | | Beta (3Y vs SPY)0.86 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 No 13F holders on file for TNG.PA. Latest reported quarters No reported quarters on file for TNG.PA. Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
